510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Medley ETCO2 Module (Includes Accessories), Model 8300

K031741510(k) TraditionalCleared Feb 9, 2004250-day reviewClass II21 CFR 868.1400Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alaris Medical Systems, Inc. · CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase

Cleared on Feb 9, 2004 as substantially equivalent to K964239 (Spegas Industries, Ltd., 1997) after a 250-day review. Its family tree reaches back 2 generations to 1995. It has been recalled 2 times.

Decided
Feb 9, 2004
Review
250 days
Class
Class II
Product code
CCK
Recalls
2
Predicates
1

Its longest line of descent runs back 2 generations to K950387 (1995). No later device cites it as a predicate yet.

K950387 · Gemini · Spegas Industries, Ltd. · 1995K964239 · Combination Oximeter/Carbon Dioxide Gas Analyzer · Spegas Industries, Ltd. · 1997199619982000200220042006
  1. Root · 2 generations backK950387 GeminiSpegas Industries, Ltd. · 1995
  2. 1 generation backK964239 Combination Oximeter/Carbon Dioxide Gas AnalyzerSpegas Industries, Ltd. · 1997
  3. This deviceK031741 Medley ETCO2 Module (Includes Accessories), Model 8300Alaris Medical Systems, Inc. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K950387GeminiSpegas Industries, Ltd.1995—
−1K964239Combination Oximeter/Carbon Dioxide Gas AnalyzerSpegas Industries, Ltd.1997—
0 (this device)K031741Medley ETCO2 Module (Includes Accessories), Model 8300Alaris Medical Systems, Inc.2004—
FIG. 1 — Lineage of K031741, 1995–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CCK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CCK device

  1. #1 K253030 Capnostream™35 Portable Respiratory Monitor…score 15.8 · 16 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964239Combination Oximeter/Carbon Dioxide Gas Analyzer
Summary page 1
…n Rate (RR) on patients in the operating room, ICU, NICU, transport and emergency treatment. This capnograph technology originates from the MediCap/NPB-75 (K964239). The current 0 05 53 === Page 2…
Spegas Industries, Ltd.1997—

Also cleared against K964239: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 1, 2019Class IIZ-2443-2019Employee errorCalibration; it has been determined that the capnographs may have been calibrated during manufacturing using a lower than specified concentration of CO2
Nov 12, 2015Class IIZ-0455-2016OtherCareFusion is recalling the Alaris EtCO2 module model 8300 because it may have been tested during service using a higher than specified concentration of CO2. The effect to the EtCO2 module tested with a higher concentration of CO2 could…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 6.8 years on median.
  • None of the 2 ancestors has a recall.
  • 6 other devices also cite its predicate K964239.

How does its category compare?

All CCK devices

CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CCK

3in 2025

2007: 52008: 32009: 32010: 32011: 22012: 72013: 42014: 92015: 52016: 22017: 52018: 62019: 72020: 42021: 42022: 32023: 42024: 32025: 32026 (partial year): 3
2007high 9 (2014) · low 2 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CCK

169in 2025

2007: 56 days median2008: 248 days median2009: 101 days median2010: 125 days median2012: 150 days median2013: 132 days median2014: 166 days median2015: 105 days median2017: 134 days median2018: 296 days median2019: 261 days median2020: 188 days median2021: 227 days median2022: 226 days median2023: 555 days median2024: 592 days median2025: 169 days median2026 (partial year): 224 days median
2007high 592 (2024) · low 56 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CCK

1in 2022

2008: 12009: 192010: 42011: 142012: 32013: 2, 1 Class I2015: 12018: 52019: 7, 7 Class I2020: 12022: 1
2007high 19 (2009) · low 0 (2007)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · CCK

1,259in 2025

2007: 72008: 202009: 212010: 122011: 182012: 132013: 282014: 512015: 1142016: 882017: 582018: 632019: 1412020: 2,3022021: 2,2722022: 2,4752023: 1,6372024: 1,2162025: 1,259
2007high 2,475 (2022) · low 7 (2007)2025

MAUDE reports naming product code CCK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200755607
20083248120
200931011921
20103125412
20112—1418
20127150313
201341322 (1)28
20149166051
201551051114
20162—088
20175134058
20186296563
201972617 (7)141
2020418812,302
2021422702,272
2022322612,475
2023455501,637
2024359201,216
2025316901,259
202632240—

What is it indicated for?

The Medley EtCO 2 Module is a capnograph that continuously monitors end tidal carbon dioxide (EtCO2 ), fractional inspired carbon dioxide (FiCO 2 ), and respiratory rate (RR). The monitor is intended for use by professional healthcare providers where continuous, non-invasive monitoring of these parameters is desired.

The MedleyT' EtCO 2 Module is indicated for use on adults, pediatrics and infant/neonates for both intubated and non-intubated patients.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031741: Medley ETCO2 Module (Includes Accessories), Model 8300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K031741

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026